Global X ReSolve Adaptiv...【HRAA】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
ETF
カナダ
TSX
Global X ReSolve Adaptive Asset Allocation Corporate Class ETF (HRAA) 銘柄情報

Global X ReSolve Adaptive Asset Allocation Corporate Class ETF (HRAA)

11.86

0.00

( 0.00% )

更新日時： 23:00:30

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

11.86

買値

11.86

売値

11.93

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

11.86

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

7,853,000

配当利回り

-

PER

114.26

1 株当たり利益 (EPS)

0.1

歳入

2.28M

純利益

815k

セクター

Finance Services

業界

Finance Services

本社

Toronto, Ontario, Can

設立

1970

Global X ReSolve Adaptive Asset Allocation Corporate Class ETF is listed in the Finance Services sector of the トロント証券取引所 with ticker HRAA. The last closing price for Global X ReSolve Adaptiv... was $11.86. Over the last year, Global X ReSolve Adaptiv... shares have traded in a share price range of $ 0.00 to $ 0.00.

Global X ReSolve Adaptiv... currently has 7,853,000 shares in issue. The market capitalisation of Global X ReSolve Adaptiv... is $93.14 million. Global X ReSolve Adaptiv... has a price to earnings ratio (PE ratio) of 114.26.

Update

RNS Number:1500G Maverick Entertainment Group PLC 23 October 2007 Maverick Entertainment Group plc ("the Company" or "Maverick") Update Further to the announcement made on 2 July...

Statement re. Suspension

RNS Number:3712Z Maverick Entertainment Group PLC 02 July 2007 Maverick Entertainment Group plc ("the Company") Suspension of shares on AIM The Company wishes to announce that its...

Suspension - Maverick Entert

RNS Number:3796Z AIM 02 July 2007 NOTICE (392) 02/07/2007 7:00am TEMPORARY SUSPENSION OF TRADING ON AIM MAVERICK ENTERTAINMENT GROUP PLC Trading on AIM for the...

Director/PDMR Shareholding

RNS Number:1183V Maverick Entertainment Group PLC 18 April 2007 Maverick Entertainment plc ("Maverick Entertainment" or "the Company") Directors Shareholding In accordance with...

Total Voting Rights

RNS Number:0445O Maverick Entertainment Group PLC 15 December 2006 Maverick Entertainment Group plc ("Maverick") or (the "Company") Total Voting Rights For the purposes of the...

Six Months To 30 June 2006

RNS Number:6699J Maverick Entertainment Group PLC 29 September 2006 29 September 2006 Maverick Entertainment Group PLC Interim Results for the six months to 30 June 2006 Further...

Issue of Equity

RNS Number:8846G Maverick Entertainment Group PLC 28 July 2006 Maverick Entertainment Group plc ("the Company") Placing Maverick Entertainment Group plc, the AIM listed company...

Trading Statement

RNS Number:4645G Maverick Entertainment Group PLC 20 July 2006 20th July 2006 Maverick Entertainment Group plc Trading Update Maverick Entertainment Group PLC ("Maverick" or "the...

Result of AGM

RNS Number:3076F Maverick Entertainment Group PLC 28 June 2006 28 June 2006 Maverick Entertainment Group PLC Result of AGM Maverick Entertainment Group PLC confirms that all...

Issue of Equity

RNS Number:2172D Maverick Entertainment Group PLC 18 May 2006 Maverick Entertainment Group plc Placing Maverick Entertainment Group PLC ("Maverick" or "the Company"), the AIM listed...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
IMNNImunon Inc	US$ 3.05 (156.30%)	83.18M
ATPCAgape ATP Corporation	US$ 0.173 (97.71%)	94.35M
PCSAProcessa Pharmaceuticals Inc	US$ 2.51 (47.65%)	37.1M
TWOU2U Inc	US$ 3.5341 (33.36%)	12.58M
JTAIJet AI Inc	US$ 0.385 (28.81%)	44.65M
QXOQXO Inc	US$ 12.225 (-79.79%)	8.75M
NIPGNIP Group Inc	10.78 (-34.67%)	1.14M
BIMIBIMI International Medical Inc	US$ 0.7921 (-31.72%)	190.99k
CNSPCNS Pharmaceuticals Inc	US$ 0.715101 (-31.24%)	24.39M
BLMZBloomZ Inc	US$ 1.8104 (-29.56%)	318.4k
ATPCAgape ATP Corporation	US$ 0.173 (97.71%)	94.35M
IMNNImunon Inc	US$ 3.05 (156.30%)	83.18M
NVDANVIDIA Corporation	US$ 108.26 (-2.98%)	59.83M
JTAIJet AI Inc	US$ 0.385 (28.81%)	44.65M
ENVBEnveric Biosciences Inc	US$ 0.64 (28.51%)	42.23M

gt1217

Where do people honestly think this could go? I only have 7500 at .49 but I might double my position.

karlacorn3

karlacorn3 1分前

Thanks, Laxmi. I'll be sure to provide the required info prior to August 2, 2024.
K

ttottip

ttottip 2分前

Vancmike

Vancmike 2分前

Rodney, Thanks for your reply

My non-accounting brain has a hard time with distributed dividends of $4,477 to senior preferred stock. An amount that disappears from the bottom line, during a suspended period.

Money Management

Money Management 2分前

He had accomplished stealing shareholder money by using deception

BBANBOB

BBANBOB 2分前

IF FAIR and REASONABLE, I am all for shutting it down, but BUTT not interested in a settlement that we will need astro glide

Step-by-Step

Step-by-Step 2分前

There were those fear mongering comments about placing Baez as new ceo and JP assuming chairman position. Makes absolute sense that JP would place Baez as ceo since he has the absolute expertise that JP certainly cannot equal in the direction the business is taking. Day to day operations should i

Drugdoctor

Drugdoctor 2分前

Looks like $FORW announcement is imminent. Usually get the best buy in prices when the board goes quiet and the stock price hits a low, then BOOM - Sharp speaks!

surfkast

surfkast 2分前

Still no proof of short selling OTC stocks. LOL

Yo-Yo

Hey work-n-hard what’s your thoughts on this ticker getting back to a dollar?

ANTI-BAGHOLDER

ANTI-BAGHOLDER 2分前

$TMEF ITEM 1.01ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

On June 10, 2024, the Company entered into an Agreement for the Acquisition of Lucent, Inc.

Further information on Lucent can be found at https://www.lucentna.com and https://w

dstock07734

dstock07734 2分前

Oncovir fixed the link issue. Just like us, the longs, I suspect Oncovir has been waiting too.

https://www.oncovir.com/new-page

neomania

neomania 3分前

We all know this is a SCAM, only hope for pumpers is when JT signs 10 Q WITH FAKE NUMBERS.I don't think anybody will buy into that, and this tanks.

Cowpie88

Cowpie88 3分前

We’ve waited long enough…

trunkmonk

trunkmonk 3分前

did something happen that i have not heard about? decoupling is easy once SEC clears up. Its got to go up a lot in order to catch up with the rest of the crypto, its even behind worthless coins and outright scams.

SmallCapStockAlert

SmallCapStockAlert 3分前

$CLNV just secured the final approval for $15 million to start building Plastic Conversion plant in West Virginia. 2 cent shares could roar to new highs breaking 12-month high of 7.4 cents. https://finance.yahoo.com/news/clean-vision-corporation-secures-amended-134500922.html

hweb2

IDR also some strange commentary from the CEO. I read through lots & lots of earnings reports...and def would NOT include some of this language in my official earnings PR. Not sure if the guy had a few drinks or what. But it didn't leave me feeling great about the company-

Mr. Swal

fink

Only $ you make is your $1,200 welfare deposit from Biden.
We all know you. You've been cramming your ego down our throats for years.
If ihub were shut down you would not have a life.

RickNagra

RickNagra 3分前

ilovetech

ilovetech 3分前

dstock - Indeed, very sad but not surprising. Those of us who follow raw, unfiltered, self-funded sources of newsworthy information have known, and have seen the alarming trends over the past three years. The most noteworthy excessive increases are in Cardiovascular/Stroke, Neurological, and Cancer

PRIVATE SHAREHOLDER

PRIVATE SHAREHOLDER 3分前

Market makers sift out day traders. Good buy opportunity .0008

kund

I think they will dilute this week, possibly today after hours, with news of a $50 million raise through some Wall Street firm. I doubt the EMA filing is coming; they are likely aiming for a larger phase 3 for AD. Before announcing that, they need to raise significant funds.

meixatech

meixatech 3分前

Allosterism in Drug Discovery (2016) Chapter 14 "The positive mnemonic effects of positive modulators of the a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor have been well documented in the preclinical setting. This encouraging level of target validation has galvanised efforts

novascotiaSTS

novascotiaSTS 3分前

Nice WSJ article

So while some banks have been exiting the business of generating or buying lots of servicing rights, Mr. Cooper has been among the buyers. Its servicing portfolio was $1.2 trillion as of the second quarter, up 37% from a year prior.

As of the first qua

Builder1960

Builder1960 3分前

Loko we’re in the same boat!!

Holding my breath with crossed fingers!!

$NSAV

$PATIENCE PAYS

Global X ReSolve Adaptiv...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約